ANTI MOG ANTIBODIES

The Anti-MOG (Myelin Oligodendrocyte Glycoprotein) Antibodies Test is a specialized blood test that detects autoantibodies against Myelin Oligodendrocyte Glycoprotein (MOG), a protein found on the surface of myelin-producing cells in the central nervous system. These antibodies are associated with MOG Antibody-Associated Disease (MOGAD), an autoimmune inflammatory disorder affecting the brain, spinal cord, and optic nerves.

MOGAD is distinct from Multiple Sclerosis (MS) and Neuromyelitis Optica Spectrum Disorder (NMOSD) and requires a different diagnostic and treatment approach. The Anti-MOG Antibodies Test helps neurologists identify autoimmune demyelinating diseases and distinguish MOGAD from other neurological conditions.

Benefits of the Test

• Detects Anti-MOG antibodies with high accuracy.
• Helps diagnose MOG Antibody-Associated Disease (MOGAD).
• Assists in differentiating MOGAD from Multiple Sclerosis and NMOSD.
• Supports evaluation of optic neuritis and transverse myelitis.
• Helps guide treatment decisions and disease monitoring.
• Assists neurologists in diagnosing autoimmune demyelinating disorders.

Why Doctors Recommend This Test

Doctors may recommend the Anti-MOG Antibodies Test for individuals with symptoms suggestive of inflammatory demyelinating disorders, including:

• Sudden vision loss or blurred vision (optic neuritis)
• Eye pain, especially during eye movement
• Weakness in the arms or legs
• Numbness or tingling
• Difficulty walking or maintaining balance
• Bladder or bowel dysfunction
• Recurrent episodes of neurological symptoms
• Acute disseminated encephalomyelitis (ADEM), especially in children
• Suspected autoimmune disorders affecting the brain or spinal cord

The test is commonly ordered along with Anti-AQP4 (Aquaporin-4) Antibody Test, MRI Brain and Spine, Cerebrospinal Fluid (CSF) analysis, visual evoked potentials, and other neurological investigations.

Preparation Before Test

• No fasting is required.
• Continue regular medications unless advised otherwise by your physician.
• Inform your healthcare provider about neurological symptoms, previous autoimmune diseases, infections, and current medications.
• A blood sample is collected for laboratory analysis.

Normal Reporting Time

Reporting Time: Usually 5–10 working days, depending on laboratory processing protocols.

Who Should Take This Test?

This test is recommended for:

• Individuals with suspected MOG Antibody-Associated Disease (MOGAD).
• Patients with recurrent optic neuritis.
• Individuals with transverse myelitis.
• Patients with acute disseminated encephalomyelitis (ADEM).
• Individuals with unexplained inflammatory neurological symptoms.
• Patients referred by neurologists for autoimmune demyelinating disease evaluation.

Patient-Friendly Summary

The Anti-MOG Antibodies Test is a blood test that detects antibodies against Myelin Oligodendrocyte Glycoprotein (MOG), a protein that helps protect nerve fibers in the brain and spinal cord. When the immune system mistakenly attacks this protein, it can lead to MOG Antibody-Associated Disease (MOGAD), causing inflammation of the optic nerves, spinal cord, or brain. Symptoms may include sudden vision loss, eye pain, weakness, numbness, balance problems, or difficulty walking. This test helps doctors distinguish MOGAD from conditions such as Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder, allowing appropriate treatment and long-term management. The test is safe, requires only a blood sample, and generally does not require fasting.